• International Endovascular Corporation

    Advancing Next-Generation Vascular Technologies

    International Endovascular Corporation (IEVC) is focused on acquiring, developing, and commercializing innovative technologies for the treatment of vascular disease.

    The company combines experienced leadership, capital-efficient operations, and established technical infrastructure to selectively commercialize differentiated, clinically validated, medical device platforms.

    Our flagship product, the DABRA™ Laser System addresses complex peripheral artery disease through minimally invasive plaque modification and vessel preparation. Utilizing innovative excimer laser and catheter technology, DABRA is engineered to cross and treat a wide range of lesion morphologies while minimizing vessel trauma and reducing the risk of distal embolization.

    View DABRA in clinical use during a peripheral endovascular intervention.

    The DABRA Laser System is indicated for crossing chronic total occlusions in patients with symptomatic infrainguinal lower extremity vascular disease. Data on file.

  • Experienced Execution. Strategic Focus.

    IEVC’s strategy includes:

    • Acquisition of underutilized or under-commercialized vascular technologies

    • Advancement of clinical and regulatory pathways

    • Reintroduction and scaling of proven technologies

    • Exploration of additional vascular applications and indications

Cookie Use
We use cookies to ensure a smooth browsing experience. By continuing we assume you accept the use of cookies.
Learn More